Decipher Labs Ltd
BSE:524752
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
This alert will be permanently deleted.
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| IN |
|
Decipher Labs Ltd
BSE:524752
|
78.8m INR |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
985.1B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
554.2B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
281B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
217.8B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
224.3B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
281.3B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.6T DKK |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
150.9B USD |
Loading...
|
|
| FR |
|
Sanofi SA
PAR:SAN
|
97.3B EUR |
Loading...
|
Market Distribution
| Min | -305 007.7% |
| 30th Percentile | 2.1% |
| Median | 5.8% |
| 70th Percentile | 11.6% |
| Max | 1 221 633.3% |
Other Profitability Ratios
Decipher Labs Ltd
Glance View
Decipher Labs Ltd. engages in the business of manufacturing pharmaceutical formulations. The company is headquartered in Hyderabad, Telangana. The firm is involved in promoting and developing in the field of pharmaceuticals, combat drugs boasts of pharmaceutical and allied products which are manufactured in multiple locations. The company provides pharmaceutical formulations such as solid dosage forms, liquid dosage forms, and ointments. The Company’s wholly owned subsidiaries include RA Labs Pte Ltd, Singapore and ICP Solutions Private Limited, India.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Decipher Labs Ltd is -52.2%, which is below its 3-year median of -10.5%.
Over the last 3 years, Decipher Labs Ltd’s Net Margin has decreased from 25.8% to -52.2%. During this period, it reached a low of -52.2% on Jul 30, 2025 and a high of 26.4% on Sep 30, 2022.